Irene Braña

Home Tag

Irene Braña VHIO

First patient in the world treated with a new therapeutic strategy to target cancer stem cells

A new drug originally developed by Leukos Biotech S.L., a spin-off of the Josep Carreras Leukaemia Research Institute, in collaboration…

Composicióin Dra. Elena Garralda y Dr. Rodrigo Toledo con batas VHIO

VHIO researchers demonstrate the utility of ultrasensitive liquid biopsy to predict and monitor response to immunotherapy

The ultrasensitive liquid biopsy technique applied in this work is based on the sequencing of the entire tumour genome from…

Banner web VHIO (1300 × 600 px) (6)

Preliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential second generation epigenetic therapy for advanced solid tumor

Published in the journal Clinical Cancer Research (1), preliminary results of a two-part, phase I first-in-human study show encouraging antitumor…

Dra. Irene Braña

Vall d’Hebron participates in a study that supports the use of pembrolizumab in head and neck squamous cell carcinoma with new data confirming its long-term efficacy

The five-year follow up data from patients in the KEYNOTE-048 trial have been reported, with the participation of Dr. Irene…